Benzinga | Mar 9, 2021 05:50PM EST

Aquestive Therapeutics Q4 EPS $(0.60) Misses $(0.26) Estimate, Sales $7.15M Beat $6.25M Estimate

Aquestive Therapeutics (NASDAQ:AQST) reported quarterly losses of $(0.60) per share which missed the analyst consensus estimate of $(0.26) by 130.77 percent. This is a 25 percent decrease over losses of $(0.48) per share from the same period last year. The company reported quarterly sales of $7.15 million which beat the analyst consensus estimate of $6.25 million by 14.38 percent. This is a 56.46 percent decrease over sales of $16.42 million the same period last year.